Blood and tissue products are highly regulated and are expected to have validated processes and procedures that ensure the safety of such products. ValGenesis’s Validation Life cycle Management System (VLMS) enables blood and tissue handling organizations to improve compliance, enforce consistency, reduce validation cycle time, and cut costs for all validation activities.

ValGenesis allows blood and tissue organizations to efficiently manage the validation process while enforcing good documentation practices (GDP), validation procedures, and compliance guidelines from regulatory agencies/industry associations—such as the FDA and AABB (American Association of Blood Banks). With ValGenesis, validation deliverables (from all types of processes and changes) reside in a single, easy-to-configure, web-based system that integrates and consolidates data and information from quality assurance, donor collections, hospital services, laboratory services, and other departments.



Efficient, paperless CSV

Press Releases

A Global Leader in Genomics Chooses ValGenesis VLMS to Manage its Validation Process